UCL93 - Normal human kidney cortical epithelial cell line

A patient-derived control cell line for studying normal kidney cell phenotype
Technology No. 41024-2

The UCL93 cell line is an immortalised human kidney cell line, derived from healthy patient tissue.

Primary cells, isolated from surplus normal kidney tissue obtained at nephrectomy (performed for limited renal cell carcinoma), were cultured and transduced with retroviral vectors containing a temperature-sensitive SV40T antigen and the catalytic subunit of telomerase. 

Along with the OX161 ADPKD cell line, these cell lines are useful in vitro models to study normal and disease-specific ADPKD phenotypes or pathways.


Ordering

Particular attention should be paid when selecting the licence, and reviewing the associated T&Cs.


Available licences:

  • 2 year restricted-use licence: Permitted use of the described cell line for a 2 year term. No cell line modifications are permitted (see licence T&Cs for more info) 
  • Perpetual licence: Permitted use of the described cell line with no time restrictions. The customer is permitted to produce cell line modifications.


Delivery and checkout questions

A £50 charge is added at checkout to cover packing and shipping costs. The material will be packaged with dry ice and prepared for shipping.

The customer will be required to provide a courier account code for which the shipping will be charged to.

The customer is also asked to provide details of their intended use for the material.

For International orders: The University ships this material internationally using INCOTERMS Ex Works (EXW). Under these terms, the buyer takes responsibility for the shipment and associated costs, including any customs duties incurred.


Keywords

UCL93, UCL-93, ADPKD, Autosomal Dominant Polycystic Kidney Disease, Kidney Cells, Renal, immortalised, immortalized


Further information

Further information on the research group and providing researcher may be found at:

https://www.sheffield.ac.uk/medicine/people/iicd/albert-cm-ong


Associated journal references

Streets AJ, Newby LJ, O'Hare MJ, Bukanov NO, Ibraghimov-Beskrovnaya O, Ong AC. Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion. J Am Soc Nephrol. 2003 Jul;14(7):1804-15.

https://doi.org/10.1097/01.ASN.0000076075.49819.9B


E. Parker, L.J. Newby, C.C. Sharpe, S. Rossetti, A.J. Streets, P.C. Harris, M.J. O'Hare, A.C.M. Ong. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. Kidney International. 2007; 72(2): 157-165.

https://doi.org/10.1038/sj.ki.5002229


Lannoy M, Valluru MK, Chang L, Abdela-Ali F, Peters DJM, Streets AJ, Ong ACM. The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney Int. 2020 Aug;98(2):404-419. doi: 10.1016/j.kint.2020.02.012. Epub 2020 Mar 6. PMID: 32622526.

https://doi.org/10.1016/j.kint.2020.02.012


Streets AJ, Prosseda PP, Ong AC. Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signaling. JCI Insight. 2020 Aug 20;5(16):e135385.

https://doi.org/10.1172/jci.insight.135385


  • swap_vertical_circlemode_editAuthors (1)
    Prof Albert Ong
  • swap_vertical_circlecloud_downloadSupporting documents (0)
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Commercial use licence - UCL93 cells: 2 year, restricted use (no modifications)
Permitted use of the cell lines for a 2 year term, with no right to produce modifications

Term: 2 years

Price per unit:
£20,000.00 excl. VAT

Commercial use licence - UCL93 cells: Perpetual
Permitted use of the cell lines, without restrictions on the production of modifications (Perpetual term)

Term: perpetual

Price per unit:
£50,000.00 excl. VAT

Questions about this technology?